Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 214408
Company: ACCORD HLTHCARE
Company: ACCORD HLTHCARE
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 100MG BASE/4ML (EQ 25MG BASE/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | Yes | No |
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 500MG BASE/20ML (EQ 25MG BASE/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | Yes | No |
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 850MG BASE/34ML (EQ 25MG BASE/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | Yes | No |
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 1GM BASE/40ML (EQ 25MG BASE/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/19/2022 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214408s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214408Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/214408Orig1s000TOC.html |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 01/16/2025 | SUPPL-5 | Labeling-Container/Carton Labels |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/214408Orig1s005ltr.pdf |
| 10/13/2023 | SUPPL-3 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214408s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214408Orig1s003ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 10/13/2023 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214408s003lbl.pdf | |
| 07/19/2022 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214408s000lbl.pdf |